F Porcellati, P Rossetti, S Pampanelli, CG … - Diabetic …, 2004 - interscience.wiley.com Methods One hundred and twenty-one patients with T1 DM on intensive therapy on four
times/day NPH and lispro insulin at each meal, were randomized to either continuation of NPH
four times/day (n = 60), or once daily glargine at dinner-time (n = 61) for 1 year. Lispro ... Cited by 106 - Related articles - BL Direct - All 4 versions
SR Heller, S Colagiuri, S Vaaler, BHR … - Diabetic …, 2004 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 68 - Related articles - BL Direct - All 4 versions
RP Hoogma, PJ Hammond, R Gomis, D Kerr, … - Diabetic …, 2006 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 59 - Related articles - BL Direct - All 5 versions
J Wainstein, M Metzger, M Boaz, O Minuchin, Y … - Diabetic …, 2005 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 31 - Related articles - BL Direct - All 4 versions
R Schiaffini, P Ciampalini, S Spera, M Cappa … - Diabetes/Metabolism … - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 26 - Related articles - All 3 versions
MR DeFelippis, MA Bell, JA Heyob, SM … - Diabetes Technology & …, 2006 - liebertonline.com Background: The stability of insulin lispro for use in continuous subcutaneous insulin infu- sion
(CSII) therapy was evaluated using a stress test incorporating high temperature and me- chanical
agitation combined with simulated basal/bolus administration. Methods: Insulin lispro ... Cited by 12 - Related articles - BL Direct - All 3 versions
J Chen, T Lauritzen, JJ Christiansen, LH Jensen, … - Diabet. Med., 2005 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 8 - Related articles - All 7 versions
DM Karl - Current Diabetes Reports, 2004 - Springer Introduction Relative insulin deficiency, a defect that worsens progres- sively over time, is now
recognized to be an essential feature of type 2 diabetes mellitus [1]. Because of this natu- ral
history, most patients with type 2 diabetes will eventu- ally need insulin treatment to ... Cited by 4 - Related articles - BL Direct - All 2 versions
RD White - Primary Care: Clinics in Office Practice, 2007 - Elsevier Continuous subcutaneous insulin infusion has provided patients who have diabetes with a system
for achieving treatment targets with a lower incidence of severe hypoglycemia. Patients prefer
the flexibility, convenience, and physiologic glycemic control of continuous subcutaneous ... Cited by 3 - Related articles - All 2 versions
